Close Menu
Home » Oxford Nanopore

Oxford Nanopore

Oxford Nanopore Technologies was founded in 2005 to develop an electronic, single molecule sensing system based on nanopore science. The company now has more than 250 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialization. Oxford Nanopore's instruments — MinIon, PromethIon, and GridIon are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule.

Oxford Nanopore Facts

 

CEO: Gordon Sanghera

Website: www.nanoporetech.com

Ticker symbol: Privately held

Headquarters: Oxford, UK

Number of employees: 250+

Nov 13, 2019

Illumina Proposes Opening PacBio IP to Competitors to Save Acquisition Deal

In a response to the UK CMA's findings that the PacBio deal would lessen competition, Illumina said it would be open to licensing some IP to Oxford Nanopore.

Nov 04, 2019

Shield Bio Brings Nanopore Sequencing to Patients Through STI Test Service

Premium

A San Jose, California-based company appears to be the first in the US to routinely offer nanopore sequencing as part of a testing lab service. 

Sep 24, 2019

NIH Awards $29.5M to Two Centers for New Human Genome Reference Program

Using 350 human genomes from different populations, the two centers plan to develop a multi-genome reference sequence that is as complete as possible.

Sep 19, 2019

Oxford Nanopore Licenses CRISPR-Cas9 IP From Caribou Biosciences for Targeted Nanopore Sequencing

The firm said CRISPR will enable targeted sequencing of long regions of interest that were previously only accessible with long-read whole-genome sequencing.

Sep 11, 2019

Oxford Nanopore Responds in Court to Pacific Biosciences Allegations of Willful Infringement

The UK-based sequencing technology firm continues to seek invalidation of PacBio's patents, despite unsuccessful earlier efforts.

Sep 03, 2019

Denmark's Samplix Plans Commercial Expansion to Support Rollout of Xdrop System

Premium

The company believes that Xdrop will find adopters in academia and clinical research, although diagnostics is on its radar.

Jul 18, 2019

European Patent Office Revokes Second Pacific Biosciences Patent

The patent, EP3170904, "Compositions and methods for nucleic acid sequencing," is the second PacBio patent revoked by the EPO this year. 

Jul 08, 2019

Oxford Nanopore 2018 Revenues More Than Double; Firm Opens New Production Facility

In a message posted on Twitter today, Oxford Nanopore said that revenues grew to $43.7 million last year, up from $17.8 million in 2017.

May 24, 2019

Oxford Nanopore Previews Upcoming Products, Outlines Nanopore-Based DNA Data Storage Tech

Premium

At the company's annual user meeting in London, staff members previewed upgrades and changes that will result in higher throughput and accuracy at lower sequencing costs.

Apr 29, 2019

GrandOmics, Oxford Nanopore Partner on 100K Human Genomes Structural Variation Project

The project plans to sequence 20,000 genomes in 2019, 50,000 by the end of 2020, and a total of 100,000 by the end of 2021 using Oxford Nanopore's PromethIon platform.

Pages

The Scan

One Year On

The University of California, Berkeley's Jennifer Doudna reflects at Science on the anniversary of the announcement of the birth of twin girls who underwent genome editing.

Gigantopithecus' Place in the Family

By studying its enamel proteome, researchers have found the ancient ape Gigantopithecus blacki belongs to a sister clade to that of orangutans.

With BGI There

Bloomberg Businessweek discusses genomics with BGI's Wang Jian.

Science Papers Describe How Gut Microbiome Transplant Affects Neuron Growth, More

In Science this week: researchers find transplanting the gut microbiome in mice affects physiology, and more.

What's Popular?

In Pacific Biosciences

  1. Illumina Proposes Opening PacBio IP to Competitors to Save Acquisition Deal

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.